261 related articles for article (PubMed ID: 17876386)
21. Recurrent tendinitis after treatment with two different fluoroquinolones.
Burkhardt O; Köhnlein T; Pap T; Welte T
Scand J Infect Dis; 2004; 36(4):315-6. PubMed ID: 15198194
[TBL] [Abstract][Full Text] [Related]
22. Is gender a risk factor for adverse drug reactions? The example of drug-induced long QT syndrome.
Drici MD; Clément N
Drug Saf; 2001; 24(8):575-85. PubMed ID: 11480490
[TBL] [Abstract][Full Text] [Related]
23. QT prolongation and torsade de pointes induced by fluoroquinolones: infrequent side effects from commonly used medications.
Briasoulis A; Agarwal V; Pierce WJ
Cardiology; 2011; 120(2):103-10. PubMed ID: 22156660
[TBL] [Abstract][Full Text] [Related]
24. Long QT syndrome and torsade de pointes associated with Takotsubo cardiomyopathy.
Ahn JH; Park SH; Shin WY; Lee SW; Lee SJ; Jin DK; Lee HM; Eun JY
J Korean Med Sci; 2011 Jul; 26(7):959-61. PubMed ID: 21738353
[TBL] [Abstract][Full Text] [Related]
25. Drug-induced long QT and torsade de pointes: recent advances.
Kannankeril PJ; Roden DM
Curr Opin Cardiol; 2007 Jan; 22(1):39-43. PubMed ID: 17143043
[TBL] [Abstract][Full Text] [Related]
26. Moxifloxacin-induced QT interval prolongation and torsades de pointes: a narrative review.
Khan F; Ismail M; Khan Q; Ali Z
Expert Opin Drug Saf; 2018 Oct; 17(10):1029-1039. PubMed ID: 30193085
[TBL] [Abstract][Full Text] [Related]
27. Rate smoothing with cardiac pacing for preventing torsade de pointes.
Viskin S; Glikson M; Fish R; Glick A; Copperman Y; Saxon LA
Am J Cardiol; 2000 Nov; 86(9A):111K-115K. PubMed ID: 11084109
[TBL] [Abstract][Full Text] [Related]
28. Bradycardia-associated torsade de pointes and the long-QT syndromes: a case report and review of the literature.
Ashworth SW; Levsky ME; Marley CT; Kang CS
Mil Med; 2005 May; 170(5):381-6. PubMed ID: 15974204
[TBL] [Abstract][Full Text] [Related]
29. Moxifloxacin-dependent Torsades de Pointes.
Tiryakioğlu SK; Tiryakioğlu O; Aktürk F; Mehmetoğlu E; Kumbay E
Anadolu Kardiyol Derg; 2011 Sep; 11(6):560-2. PubMed ID: 21827995
[No Abstract] [Full Text] [Related]
30. QT interval prolongation, torsade de pointes and renal disease.
Patanè S; Marte F; Di Bella G; Currò A; Coglitore S
Int J Cardiol; 2008 Nov; 130(2):e71-3. PubMed ID: 18255176
[TBL] [Abstract][Full Text] [Related]
31. Moxifloxacin does increase the corrected QT interval.
White CM; Grant EM; Quintiliani R
Clin Infect Dis; 2001 Oct; 33(8):1441-4. PubMed ID: 11565091
[No Abstract] [Full Text] [Related]
32. Torsade de pointes, acquired complete heart block and inappropriately long QT in childhood.
Gladman G; Davis AM; Fogelman R; Hamilton RM; Gow RM
Can J Cardiol; 1996 Jul; 12(7):683-5. PubMed ID: 8689540
[TBL] [Abstract][Full Text] [Related]
33. Ciprofloxacin- and hypocalcemia-induced torsade de pointes triggered by hemodialysis.
Daya SK; Gowda RM; Khan IA
Am J Ther; 2004; 11(1):77-9. PubMed ID: 14704599
[TBL] [Abstract][Full Text] [Related]
34. Gatifloxacin-associated corrected QT interval prolongation, torsades de pointes, and ventricular fibrillation in patients with known risk factors.
Bertino JS; Owens RC; Carnes TD; Iannini PB
Clin Infect Dis; 2002 Mar; 34(6):861-3. PubMed ID: 11830802
[TBL] [Abstract][Full Text] [Related]
35. Efavirenz-associated QT prolongation and Torsade de Pointes arrhythmia.
Castillo R; Pedalino RP; El-Sherif N; Turitto G
Ann Pharmacother; 2002 Jun; 36(6):1006-8. PubMed ID: 12022902
[TBL] [Abstract][Full Text] [Related]
36. Drug-induced long QT syndrome and torsade de pointes.
Morissette P; Hreiche R; Turgeon J
Can J Cardiol; 2005 Aug; 21(10):857-64. PubMed ID: 16107909
[TBL] [Abstract][Full Text] [Related]
37. Antiarrhythmic drugs and torsade de pointes.
Lazzara R
Eur Heart J; 1993 Nov; 14 Suppl H():88-92. PubMed ID: 8293758
[TBL] [Abstract][Full Text] [Related]
38. Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death.
Glassman AH; Bigger JT
Am J Psychiatry; 2001 Nov; 158(11):1774-82. PubMed ID: 11691681
[TBL] [Abstract][Full Text] [Related]
39. Idiopathic long QT syndrome with late onset of bradycardia-dependent and short-coupled variant of torsade de pointes.
Chiladakis J; Karapanos G; Manolis AS
Int J Cardiol; 1998 Mar; 64(1):93-5. PubMed ID: 9579821
[TBL] [Abstract][Full Text] [Related]
40. Improving the detection of subtle I(Kr)-inhibition: assessing electrocardiographic abnormalities of repolarization induced by moxifloxacin.
Couderc JP; McNitt S; Hyrien O; Vaglio M; Xia X; Polonsky S; Moss AJ; Zareba W
Drug Saf; 2008; 31(3):249-60. PubMed ID: 18302449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
